Default company panoramic image
Logo

Coagulation Sciences, LLC

The MCTS system enables caregivers to perform point-of-care analyses of blood clotting and guide optimal therapy to arrest bleeding.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location New York City, NY, USA
  • Currency USD
  • Founded September 2002
  • Employees 4
  • Website coagulationsciences.com

Company Summary

Coagulation Sciences is a blood-testing innovator that has developed a Transfusion Management System to scientifically manage blood transfusions at the patient’s point-of-care. Coagulation Sciences’ system will improve outcome for patients who are bleeding, while simultaneously reducing healthcare costs.

Team

  • Default avatar
    Sheldon Goldstein
    President
    Unconfirmed

    Dr. Goldstein is the inventor of the MCTS™ device and the visionary behind the Company’s blood transfusion related Intellectual Property. Dr. Goldstein is an Internist & Cardiac Anesthesiologist practicing at New Jersey Medical School, having received his medical degree at Hahnemann Medical College in Philadelphia (renamed Drexel/Hahnemann). Dr. Goldstein is an expert in the management of bleeding patients, and has been invited to speak on coa

  • Default avatar
    David Zimm
    Dir of Business Development
    Unconfirmed

    Mr. Zimm leads the Company’s outreach efforts in all stages. Mr. Zimm brings 20 years of start-up and business development experience. His credits include Foundation Source, the largest steward of private foundations in the US, Bold Analytics (renamed TradeStream Global Ltd), a provider of trading solutions to financial institutions, and Avant Capital, a developer of quantitative trading algorithms. Mr. Zimm holds a degree in Economics from Col

  • Default avatar
    Michael Todd Kagan
    Dir of Product Development
    Unconfirmed

    Mr. Kagan leads the development process for the Company’s devices, from prototyping and testing to manufacturing transfer and commercialization. Mr. Kagan brings 28 years of successful experience in the diagnostics industry, having worked at Immunicon, Chiron, and Ciba Corning, where he led engineering and manufacturing initiatives that resulted in FDA clearances for six in-vitro medical devices, and the associated test kits.

  • Default avatar
    Sheldon Freedman
    Dir of Investor Relations and Counsel
    Unconfirmed

    Mr. Freedman guides the Company’s capital raising strategy and acts as in-house counsel. Mr. Freedman brings 25 years of experience as a business lawyer, venture capitalist and investment banker. He is a former partner in 21 Ventures LLC, a New York venture capital firm. Mr. Freedman holds a degree in Economics from the University of Toronto and a Law degree from the University of Windsor.

Advisors

  • Default avatar
    STROOCK, STROOCK AND LAVAN, NEW YORK, NY
    Lawyer
    Unconfirmed
    Default avatar
    EISNER PC., FREEPORT, NY
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    10 Private Accredited Investors
    Unconfirmed
    Default avatar
    Friends and Family
    Unconfirmed